STOCK TITAN

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
earnings date

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2025 financial results on Wednesday, Feb. 18, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

Wednesday, Feb. 18, 2026

 

Time:

8:00 a.m. ET

 

Webcast:

https://www.webcaster5.com/Webcast/Page/2883/53392

 

Participant Event Dial-in:

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

923960

 

Replay Dial-in:

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

53392 (replay available until March 4, 2026)

About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

© 2026 Bausch + Lomb.

Media Contact:

Chris Clark

chris.clark@bausch.com

(848) 360-1100



Investor Contact:

George Gadkowski

george.gadkowski@bausch.com

(877) 354-3705 (toll free)

Source: Bausch + Lomb Corporation

Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

5.81B
38.57M
88.06%
11.29%
0.91%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN